Search

Penumbra Inc

Slēgts

SektorsVeselības aprūpe

325.39 0.41

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

323.92

Max

324.72

Galvenie mērījumi

By Trading Economics

Ienākumi

2.2M

35M

Pārdošana

15M

390M

P/E

Sektora vidējais

79.172

68.51

EPS

0.88

Peļņas marža

8.925

Darbinieki

4,700

EBITDA

5.5M

52M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+10.39% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

158M

13B

Iepriekšējā atvēršanas cena

324.98

Iepriekšējā slēgšanas cena

325.39

Ziņu noskaņojums

By Acuity

100%

0%

317 / 340 Rangs Healthcare

Penumbra Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 8. aug. 00:02 UTC

Penumbra Inc shares are trading higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

2026. g. 7. aug. 19:56 UTC

Penumbra Inc. shares are lower today, despite earlier gains, amid a broader market influenced by a disappointing jobs report and shifting monetary policy sentiment.

2026. g. 6. aug. 19:36 UTC

Penumbra Inc shares are modestly higher today, maintaining an upward trajectory. No specific company news was identified to explain the price movement.

2026. g. 5. aug. 21:03 UTC

Penumbra Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

2026. g. 4. aug. 19:36 UTC

Penumbra Inc shares are higher today, reflecting a slight gain since Monday. The stock remains above its 20-day moving average amid broader market trends.

2026. g. 3. aug. 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

2026. g. 24. jūl. 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Salīdzinājums

Cenas izmaiņa

Penumbra Inc Prognoze

Cenas mērķis

By TipRanks

10.39% augšup

Prognoze 12 mēnešiem

Vidējais 358.4 USD  10.39%

Augstākais 374 USD

Zemākais 320 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Penumbra Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

6 ratings

1

Pirkt

5

Turēt

0

Pārdot

Noskaņojums

By Acuity

317 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat